Jennifer Law
Princess Margaret Cancer Centre(CA)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Lung Cancer Diagnosis and Treatment, Ubiquitin and proteasome pathways, Hippo pathway signaling and YAP/TAZ
Most-Cited Works
- → Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival(2008)405 cited
- → Y-Box Binding Protein-1 Induces the Expression of CD44 and CD49f Leading to Enhanced Self-Renewal, Mammosphere Growth, and Drug Resistance(2010)166 cited
- → Clinical practice guidelines for the care of girls and women with Turner syndrome(2024)157 cited
- → Analytical and Preanalytical Biases in Serum Proteomic Pattern Analysis for Breast Cancer Diagnosis(2005)124 cited
- → The evolution of geographic parthenogenesis in Timema walking‐sticks(2002)123 cited
- → Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes(2008)122 cited
- → Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial(2018)94 cited
- → Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells(2012)88 cited
- → Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1)(2013)59 cited
- → Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer(2023)58 cited